Cr. Morris et al., DISEASE PATTERNS AND SURVIVAL AFTER ACQUIRED-IMMUNODEFICIENCY-SYNDROME DIAGNOSIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN, The Pediatric infectious disease journal, 15(4), 1996, pp. 321-328
Background. The clinical manifestations of HIV infection in children i
nvolve a broad spectrum of conditions ranging from mild symptoms to AI
DS. Knowledge of the disease and survival patterns of these children a
re needed to plan for future needs and develop baseline information to
evaluate newer prophylactic or therapeutic management options. Object
ives. To identify AIDS-defining conditions and estimate post-AIDS diag
nosis survival among HIV-infected children. Methods. Disease patterns
and survival after the diagnosis of AIDS-defining conditions were stud
ied in 126 children who were identified through a multisite university
-based active surveillance system in California from January, 1989, th
rough August, 1993. Hospital medical records were periodically reviewe
d and data were abstracted onto standardized forms designed for pediat
ric HIV surveillance. We determined the length of survival between AID
S diagnosis and death and evaluated the impact of disease patterns on
survival using Kaplan-Meier's product-limit method and Cox proportiona
l hazards regression. Results. The median age at diagnosis was 13 mont
hs for children with perinatally acquired infection and 101.5 months f
or children infected through other routes of transmission, Pneumocysti
s carinii pneumonia and lymphoid interstitial pneumonia were the most
common AIDS-defining conditions among perinatal cases, whereas the dis
ease patterns observed among nonperinatal cases were more varied. The
median postdiagnosis survival for the cohort was 26 months. Conclusion
s. Survival time did not differ significantly by race/ethnicity, sex o
r route of transmission. Respiratory candidiasis and wasting syndrome
had significant negative impact on survival but P. carinii pneumonia w
as not associated with shorter survival. Zidovudine or other antiviral
therapies was associated with increased survival.